CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-13 | Ciaffoni Joseph President and CEO | Sale | −11,250 | $26.88 | $302K | 400,087 |
| 2023-02-13 | Ciaffoni Joseph President and CEO | Option exercise · Stock Option (Right to Purchase) | −11,250 | 0 | ||
| 2023-02-10 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +31,185 | 31,185 | ||
| 2023-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +48,125 | 157,620 | ||
| 2023-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Grant or award | +25,739 | 183,359 | ||
| 2023-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −16,291 | $26.75 | $436K | 167,068 |
| 2023-02-10 | Kuhlmann Shirley R. EVP and General Counsel | Shares withheld for taxes | −7,755 | $26.75 | $207K | 159,313 |
| 2023-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +45,045 | 135,349 | ||
| 2023-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +12,565 | 147,914 | ||
| 2023-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −6,967 | $26.75 | $186K | 140,947 |
| 2023-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −3,887 | $26.75 | $104K | 137,060 |
| 2023-02-10 | Ciaffoni Joseph President and CEO | Grant or award | +117,500 | 366,250 | ||
| 2023-02-10 | Ciaffoni Joseph President and CEO | Grant or award | +137,694 | 503,944 | ||
| 2023-02-10 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −44,121 | $26.75 | $1.2M | 459,823 |
| 2023-02-10 | Ciaffoni Joseph President and CEO | Shares withheld for taxes | −59,736 | $26.75 | $1.6M | 400,087 |
| 2023-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +44,275 | 147,073 | ||
| 2023-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +22,459 | 169,532 | ||
| 2023-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −14,529 | $26.75 | $389K | 155,003 |
| 2023-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −6,797 | $26.75 | $182K | 148,206 |
| 2023-01-09 | Dreyer Scott EVP & Chief Commercial Officer | Sale | −10,424 | $27.08 | $282K | 110,208 |
Page 11 of 24 · 462 trades